These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 25209793)

  • 1. Microbiology: Bacteria get vaccinated.
    Barrangou R; Klaenhammer TR
    Nature; 2014 Sep; 513(7517):175-6. PubMed ID: 25209793
    [No Abstract]   [Full Text] [Related]  

  • 2. Adaptation in bacterial CRISPR-Cas immunity can be driven by defective phages.
    Hynes AP; Villion M; Moineau S
    Nat Commun; 2014 Jul; 5():4399. PubMed ID: 25056268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR-Cas immunity leads to a coevolutionary arms race between Streptococcus thermophilus and lytic phage.
    Common J; Morley D; Westra ER; van Houte S
    Philos Trans R Soc Lond B Biol Sci; 2019 May; 374(1772):20180098. PubMed ID: 30905285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variability in the durability of CRISPR-Cas immunity.
    Chabas H; Nicot A; Meaden S; Westra ER; Tremblay DM; Pradier L; Lion S; Moineau S; Gandon S
    Philos Trans R Soc Lond B Biol Sci; 2019 May; 374(1772):20180097. PubMed ID: 30905283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic impact of CRISPR immunization against bacteriophages.
    Barrangou R; Coûté-Monvoisin AC; Stahl B; Chavichvily I; Damange F; Romero DA; Boyaval P; Fremaux C; Horvath P
    Biochem Soc Trans; 2013 Dec; 41(6):1383-91. PubMed ID: 24256225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Costs of CRISPR-Cas-mediated resistance in Streptococcus thermophilus.
    Vale PF; Lafforgue G; Gatchitch F; Gardan R; Moineau S; Gandon S
    Proc Biol Sci; 2015 Aug; 282(1812):20151270. PubMed ID: 26224708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ecology and evolution of microbial CRISPR-Cas adaptive immune systems.
    Westra ER; van Houte S; Gandon S; Whitaker R
    Philos Trans R Soc Lond B Biol Sci; 2019 May; 374(1772):20190101. PubMed ID: 30905294
    [No Abstract]   [Full Text] [Related]  

  • 8. The endless battle between phages and CRISPR-Cas systems in
    Philippe C; Moineau S
    Biochem Cell Biol; 2021 Aug; 99(4):397-402. PubMed ID: 33534660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physical model of the immune response of bacteria against bacteriophage through the adaptive CRISPR-Cas immune system.
    Han P; Niestemski LR; Barrick JE; Deem MW
    Phys Biol; 2013 Apr; 10(2):025004. PubMed ID: 23492852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How adaptive immunity constrains the composition and fate of large bacterial populations.
    Bonsma-Fisher M; Soutière D; Goyal S
    Proc Natl Acad Sci U S A; 2018 Aug; 115(32):E7462-E7468. PubMed ID: 30038015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro reconstitution of Cascade-mediated CRISPR immunity in Streptococcus thermophilus.
    Sinkunas T; Gasiunas G; Waghmare SP; Dickman MJ; Barrangou R; Horvath P; Siksnys V
    EMBO J; 2013 Feb; 32(3):385-94. PubMed ID: 23334296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phages Fight Back: Inactivation of the CRISPR-Cas Bacterial Immune System by Anti-CRISPR Proteins.
    Maxwell KL
    PLoS Pathog; 2016 Jan; 12(1):e1005282. PubMed ID: 26741979
    [No Abstract]   [Full Text] [Related]  

  • 13. CRISPR-induced distributed immunity in microbial populations.
    Childs LM; England WE; Young MJ; Weitz JS; Whitaker RJ
    PLoS One; 2014; 9(7):e101710. PubMed ID: 25000306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detecting natural adaptation of the Streptococcus thermophilus CRISPR-Cas systems in research and classroom settings.
    Hynes AP; Lemay ML; Trudel L; Deveau H; Frenette M; Tremblay DM; Moineau S
    Nat Protoc; 2017 Mar; 12(3):547-565. PubMed ID: 28207002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR-Cas9: From a bacterial immune system to genome-edited human cells in clinical trials.
    Kick L; Kirchner M; Schneider S
    Bioengineered; 2017 May; 8(3):280-286. PubMed ID: 28287876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The population and evolutionary dynamics of phage and bacteria with CRISPR-mediated immunity.
    Levin BR; Moineau S; Bushman M; Barrangou R
    PLoS Genet; 2013; 9(3):e1003312. PubMed ID: 23516369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacteriophage Cooperation Suppresses CRISPR-Cas3 and Cas9 Immunity.
    Borges AL; Zhang JY; Rollins MF; Osuna BA; Wiedenheft B; Bondy-Denomy J
    Cell; 2018 Aug; 174(4):917-925.e10. PubMed ID: 30033364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coevolution between bacterial CRISPR-Cas systems and their bacteriophages.
    Watson BNJ; Steens JA; Staals RHJ; Westra ER; van Houte S
    Cell Host Microbe; 2021 May; 29(5):715-725. PubMed ID: 33984274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-CRISPR Phages Cooperate to Overcome CRISPR-Cas Immunity.
    Landsberger M; Gandon S; Meaden S; Rollie C; Chevallereau A; Chabas H; Buckling A; Westra ER; van Houte S
    Cell; 2018 Aug; 174(4):908-916.e12. PubMed ID: 30033365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes and characterization of chromosomal self-targeting by native CRISPR-Cas systems in Streptococcus thermophilus.
    Cañez C; Selle K; Goh YJ; Barrangou R
    FEMS Microbiol Lett; 2019 May; 366(9):. PubMed ID: 31077282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.